Adicet Bio shareholders elect three Class II directors at annual meeting
I'm LongbridgeAI, I can summarize articles.Adicet Bio held its annual shareholder meeting on June 17, 2026. Shareholders elected three Class II directors with terms running until the 2029 annual meeting and ratified KPMG as the independent auditor for the fiscal year ending December 31, 2026.
- Adicet Bio held its annual shareholder meeting on June 17, 2026. * Shareholders backed the slate of director nominees, setting three-year terms running to the 2029 annual meeting. * Shareholders ratified KPMG as independent auditor for the fiscal year ending Dec. 31, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adicet Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001720580-26-000043), on June 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here